title: Papillomavirus vaccination in France according to 2008 to 2012 Vaccinoscopie(®) data.
abstract: Vaccination against human papillomavirus infections (HPV), introduced in the French vaccinal schedule in 2007, was recommended until the end of 2012 for 14-year-old girls, with a catch-up policy until 23years of age. We followed the evolution of this vaccine coverage rate (VC) during these 5years in the Vaccinoscopie(®) survey.
  
  
  METHODS
  We present the analysis of data collected in 2012 from a sample of 1136 mothers of girls 14 to 16years of age. They answered a self-administered questionnaire on Internet and reported all vaccinations mentioned in their daughter's health record.
  
  
  RESULTS
  In 2012, respectively 12.9%, 33.6%, and 48.1% of girls 14, 15 and 16years of age had begun HPV vaccination (≥1 dose received) and respectively 4.3%, 23.6%, and 40.5% of them had received a complete vaccination schedule (3 doses), i.e. 31.7% of 14-16-year-old girls had started the vaccination schedule and 22.9% were fully vaccinated. VC for ≥1 dose had decreased between 2009 and 2012 (-14 points in 14-year-old girls, -16 points in 15-year-old girls, and -11 points between 2009 and 2012 in 16-year-old girls). Regional VCs were heterogeneous.
  
  
  CONCLUSIONS
  HPV VC is clearly insufficient. It is essential that physicians concerned by HPV vaccination be mobilized and take every opportunity to inform, reassure, and vaccinate teenage girls. HPV vaccination has been recommended for girls between 11 and 14years of age since 2013, which could help improve adherence to vaccination.
authors: Service de bactériologie-virologie-hygiène, CHU Dupuytren, 2, avenue Martin-Luther-King, 87042 Limoges cedex, France.
authors: F
authors: F
authors: Denis
authors: CHU de Créteil, 40, avenue de Verdun, 94010 Créteil cedex, France.
authors: R
authors: R
authors: Cohen
authors: Service de maladies infectieuses et tropicales, CHU, université-1 de Grenoble, BP 217, 38043 Grenoble, France.
authors: J-P
authors: JP
authors: Stahl
authors: Clinique de pédiatrie, CHU de Lille, 2, avenue Oscar-Lambret, 59037 Lille cedex, France.
authors: A
authors: A
authors: Martinot
authors: GSK France, 100, route de Versailles, 78163 Marly-le-Roi, France. Electronic address: veronique.v.dury@gsk.com.
authors: V
authors: V
authors: Dury
authors: Institut des Mamans, 2, rue Balny-d'Avricourt, 75017 Paris, France.
authors: M
authors: M
authors: Le Danvic
authors: Service de pédiatrie, hôpital Jean-Verdier, 93140 Bondy, France; Université Paris-XIII, AP-HP, 93017 Bobigny, France.
authors: J
authors: J
authors: Gaudelus
mesh_terms: D000293:Adolescent; D005260:Female; D005602:France; D019983:Guideline Adherence; D019538:Health Care Surveys; D007722:Health Knowledge, Attitudes, Practice; D006291:Health Policy; D006293:Health Promotion; D006801:Humans; D007115:Immunization Schedule; D020407:Internet; D009035:Mothers / Q000523:psychology; D053918:Papillomavirus Vaccines; D011795:Surveys and Questionnaires; D014611:Vaccination / Q000706:statistics & numerical data*
chemical_list: D053918:Papillomavirus Vaccines
keywords: Adolescentes; Couverture vaccinale; Papillomavirus; Teenage girls; Vaccination; Vaccine coverage rates